The topical JAK inhibitor is the first treatment approved specifically for adults with moderate-to-severe chronic hand eczema.

Rezpegaldesleukin (Rezpeg) shows fast, effective eczema relief in Phase 2 trial with fewer side effects than other treatments, offering hope for moderate-to-severe cases.

Despite Nektar’s share price shooting up as much as 175% on Tuesday, William Blair maintained that “there is an absence of clear differentiation” for rezpegaldesleukin in the atopic dermatitis space.

A significant interaction found between a genetic variant for atopic eczema and early-life exposure to pet dogs suggests that this exposure may protect children genetically predisposed to eczema ...

I’ve had to learn that just because I don’t have eczema myself, it doesn’t mean I can remain ignorant about it and the effect it has on my kids. Not if I want to help them.

Exercise and eczema have a fraught relationship. On the one hand, sweat and hot temperatures tend to exacerbate the skin condition, which is characterized by itchy, inflamed, and dry skin. On the ...

Over the past three decades, Lora has learned a ton about eczema, including how to soothe the itch, prevent flares, and to mentally cope with the chronic condition. Here's what's worked for her.

Leo Pharma has shared phase 2b data on its eczema prospect temtokibart, reporting that the top three doses of the IL-22RA1 blocker beat placebo on the primary endpoint. Temtokibart is designed to ...

Nedorost, S. and Hammond, M. (2020) Art of Prevention Allergic Sensitization through Damaged Skin Atopic, Occupational, and Stasis Dermatitis. International Journal of Womens Dermatology, 6, 381-383.

“Eczema is a chronic skin condition that is due to a combination of genetic and environmental factors,” says Karan Lal, DO, FAAD, a Scottsdale, Arizona-based dermatologist.